March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Tariffs & and the Defense Industrial Base with Becca Wasser, plus what’s new in the U.S.-China trade war
Geoff and Emily debrief on the latest news in the U.S.-China trade talks. Becca Wasser, senior fellow and deputy director of the CNAS defense program, joins to talk about what...
By Emily Kilcrease, Geoffrey Gertz & Becca Wasser
-
Production Power: The Revitalisation of the U.S. Defence Industrial Base and the Consequences for Europe
In episode 15 of Strategy Speaks, Becca Wasser from CNAS speaks with Daniel Fiott about the US defence industrial base and how its revitalisation could affect Europe. The conv...
By Becca Wasser
-
MWI Podcast: The U.S. Defense Industrial Base, from Steel to Software
Mobilizing the U.S. defense industrial base. for a future large-scale conflict, however, will look very different than it has in the past. In the information age, data and sof...
By Becca Wasser
-
‘Spider’s Web’ Warning: The U.S. Must Prioritize Drone Defense to Avoid Russia’s Fate
This attack is wake-up call for US military: its counter-drone efforts are inadequate and are not keeping pace with the threat....
By Stacie Pettyjohn & Molly Campbell